Health Care Contracts & Agreements
149,729 Contracts from 2,089 Health Care Companies
- Biotechnology (55,767 contracts from 663 companies)
- Health Care Equipment & Supplies (27,671 | 356)
- Health Care Providers & Services (25,324 | 473)
- Health Care Technology (4,677 | 71)
- Life Sciences Tools & Services (4,863 | 64)
- Pharmaceuticals (31,427 | 462)
- Amendment No. 2 to Credit Agreement dated as of October 5, 2023 among the Company, the lenders party thereto, and JPMorgan Chase Bank, NA., as administrative agent (MESA LABORATORIES INC, Filed With SEC on November 6, 2023)
- Non-Employee Director Compensation Program (CARGO Therapeutics, Inc., Filed With SEC on November 6, 2023)
- Employment Agreement by and between the Registrant and Ginna Laport (CARGO Therapeutics, Inc., Filed With SEC on November 6, 2023)
- First Amendment to Sublease Agreement, dated August 17, 2022, by and between BigHat Biosciences, Inc. and the Registrant (f/k/a Syncopation Life Sciences, Inc.) (CARGO Therapeutics, Inc., Filed With SEC on November 6, 2023)
- Sublease Agreement, dated November 4, 2021, by and between BigHat Biosciences, Inc. and the Registrant (f/k/a Syncopation Life Sciences, Inc.) (CARGO Therapeutics, Inc., Filed With SEC on November 6, 2023)
- Form of Indemnification and Advancement Agreement for directors and officers (CARGO Therapeutics, Inc., Filed With SEC on November 6, 2023)
- Employment Agreement by and between the Registrant and Shishir Gadam (CARGO Therapeutics, Inc., Filed With SEC on November 6, 2023)
- Employment Agreement by and between the Registrant and Anup Radhakrishnan (CARGO Therapeutics, Inc., Filed With SEC on November 6, 2023)
- Employment Agreement by and between the Registrant and Gina Chapman (CARGO Therapeutics, Inc., Filed With SEC on November 6, 2023)
- Employee Stock Purchase Plan (CARGO Therapeutics, Inc., Filed With SEC on November 6, 2023)
- Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement under the 2023 Incentive Award Plan (CARGO Therapeutics, Inc., Filed With SEC on November 6, 2023)
- Form of Stock Option Grant Notice and Stock Option Agreement under the 2023 Incentive Award Plan (CARGO Therapeutics, Inc., Filed With SEC on November 6, 2023)
- 2023 Incentive Award Plan (CARGO Therapeutics, Inc., Filed With SEC on November 6, 2023)
- Form Agreements under the CARGO Therapeutics, Inc. 2021 Stock Option and Grant Plan (CARGO Therapeutics, Inc., Filed With SEC on November 6, 2023)
- Amendment No. 5 to CARGO Therapeutics, Inc. 2021 Stock Option and Grant Plan (CARGO Therapeutics, Inc., Filed With SEC on November 6, 2023)
- CARGO Therapeutics, Inc. 2021 Stock Option and Grant Plan and forms of option agreements thereunder (CARGO Therapeutics, Inc., Filed With SEC on November 6, 2023)
- Patent License Agreement, dated February 24, 2023, by and between the Registrant and the National Cancer Institute (CARGO Therapeutics, Inc., Filed With SEC on November 6, 2023)
- Patent License Agreement, dated March 16, 2022, by and between the Registrant and the National Cancer Institute (CARGO Therapeutics, Inc., Filed With SEC on November 6, 2023)
- License and Supply Agreement, dated June 24, 2022, by and between the Registrant and Oxford Biomedica (UK) Limited (CARGO Therapeutics, Inc., Filed With SEC on November 6, 2023)
- Amendment No. 1 to Exclusive License Agreement effective August 1, 2022, by and between the Registrant and the Board of Trustees of the Leland Stanford Junior University (CARGO Therapeutics, Inc., Filed With SEC on November 6, 2023)
- Exclusive License Agreement effective August 1, 2022, by and between the Registrant and the Board of Trustees of the Leland Stanford Junior University (CARGO Therapeutics, Inc., Filed With SEC on November 6, 2023)
- Amended and Restated Investors Rights Agreement, dated, February 9, 2023, by and among the Registrant and the investors listed therein (CARGO Therapeutics, Inc., Filed With SEC on November 6, 2023)
- Form of Common Stock Certificate (CARGO Therapeutics, Inc., Filed With SEC on November 6, 2023)
- Form of Underwriting Agreement (CARGO Therapeutics, Inc., Filed With SEC on November 6, 2023)
- Patent License Agreement by and between the Company and Avior Inc. dba Avior Bio dated November 3, 2023 (Hillstream BioPharma Inc., Filed With SEC on November 6, 2023)
- Executive Employment Agreement, dated November 2, 2023, by and between the Company and Lee Bienstock (Motion Acquisition Corp., Filed With SEC on November 6, 2023)
- Retention Compensation Agreement between the Company and Jonathan Freve, dated September 26, 2023 (Galecto Inc., Filed With SEC on November 6, 2023)
- Bonus Agreement between the Galecto Biotech ApS and Hans Schambye, dated September 26, 2023 (Galecto Inc., Filed With SEC on November 6, 2023)
- Form of the 25% Senior Secured Convertible Promissory Note (Kiromic Biopharma, Inc., Filed With SEC on November 6, 2023)
- Amendment to Sublease by and between, Augmedix Operating Corp. and Turo Inc., dated October 31, 2023 (Malo Holdings Corp, Filed With SEC on November 6, 2023)
- Warrant Agreement dated January 22, 2021 (Frequency Therapeutics, Inc., Filed With SEC on November 6, 2023)
- Korro Bio, Inc. Senior Executive Cash Incentive Bonus Plan (Frequency Therapeutics, Inc., Filed With SEC on November 6, 2023)
- Korro Bio, Inc. Non-Employee Director Compensation Policy (Frequency Therapeutics, Inc., Filed With SEC on November 6, 2023)
- Korro Bio, Inc. 2023 Employee Stock Purchase Plan (Frequency Therapeutics, Inc., Filed With SEC on November 6, 2023)
- Korro Bio, Inc. 2023 Stock Option and Incentive Plan, and form of award agreements thereunder (Frequency Therapeutics, Inc., Filed With SEC on November 6, 2023)
- Korro Bio, Inc. 2019 Stock Incentive Plan, and form of award agreements thereunder (Frequency Therapeutics, Inc., Filed With SEC on November 6, 2023)
- Form of Indemnification Agreement for Directors of Korro Bio, Inc (Frequency Therapeutics, Inc., Filed With SEC on November 6, 2023)
- Form of Indemnification Agreement for Officers of Korro Bio, Inc (Frequency Therapeutics, Inc., Filed With SEC on November 6, 2023)
- Registration Rights Agreement, dated July 14, 2023, by and among Korro Bio Ops, Inc. and certain parties thereto (Frequency Therapeutics, Inc., Filed With SEC on November 6, 2023)
- Subscription Agreement, dated July 14, 2023, by and among Korro Bio Ops, Inc. and certain parties thereto (Frequency Therapeutics, Inc., Filed With SEC on November 6, 2023)